Girish Venkataraman to Biomarkers, Tumor
This is a "connection" page, showing publications Girish Venkataraman has written about Biomarkers, Tumor.
Connection Strength
1.305
-
Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities. Mod Pathol. 2020 05; 33(5):834-845.
Score: 0.405
-
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood. 2013 Mar 07; 121(10):1795-804.
Score: 0.251
-
Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders. Am J Clin Pathol. 2011 Oct; 136(4):625-30.
Score: 0.230
-
Tissue microarrays: potential in the Indian subcontinent. Indian J Cancer. 2005 Jan-Mar; 42(1):9-14.
Score: 0.144
-
Challenges in the Diagnosis of Gray Zone Lymphomas. Surg Pathol Clin. 2019 Sep; 12(3):709-718.
Score: 0.098
-
Cyclin D1 expression in peripheral T-cell lymphomas. Mod Pathol. 2016 11; 29(11):1306-1312.
Score: 0.080
-
Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol. 2010 Apr; 34(4):589-94.
Score: 0.052
-
Oncocytic epithelial-myoepithelial carcinoma: an evolving new variant with comparative immunohistochemistry. Pathology. 2008 Jun; 40(4):415-8.
Score: 0.046